H. Williams
Pharmaceutical Science · with Charman · 2013
A researcher in the Science corpus: 1 paper; trusts 11 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmaceutical Science — 48 citations into it
- Materials Chemistry — 37 citations into it
- Molecular Biology — 24 citations into it
- Biomaterials — 17 citations into it
- Spectroscopy — 16 citations into it
- Pharmacology — 7 citations into it
Whom H. Williams trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- R. Müller
- M. Brewster
- T. Loftsson
- Colin W. Pouton
- E. Merisko-Liversidge
- Christopher A. Lipinski
- B. Rabinow
- J. Breitenbach
- J. Dressman
- C. Keck
Papers from H. Williams's perspective
Ordered by how strongly the researchers H. Williams trusts endorse each paper. Same corpus, a different order for every researcher.
- Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- Evaluation of cyclodextrin solubilization of drugs. (International journal of pharmaceutics)
- Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)
- What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
- Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions (Pharmaceutical Research)
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
- Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms (Pharmaceutical Research)
- Solubilizing Excipients in Oral and Injectable Formulations (Pharmaceutical Research)
- Cyclodextrin-based pharmaceutics: past, present and future (Nature reviews. Drug discovery)
Their papers
- Strategies to Address Low Drug Solubility in Discovery and Development (2013) — 1,466 citations